• All Share : 51967.0824
    DOWN -0.48%
    Top40 - (Tradeable) : 46355.5984
    DOWN -0.58%
    Financial 15 : 16620.6125
    DOWN -0.02%
    Industrial 25 : 67132.5513
    DOWN -0.64%
    Resource 10 : 38668.9489
    DOWN -1.03%

  • ZAR/USD : 12.3686
    DOWN -0.42%
    ZAR/GBP : 19.2244
    DOWN -0.43%
    ZAR/EUR : 13.6623
    UP 0.08%
    ZAR/JPY : 0.1004
    DOWN -0.99%
    ZAR/AUD : 9.2678
    DOWN -0.19%

  • Gold US$/oz : 1173.3
    UNCHANGED0.00%
    Platinum US$/oz : 1081.35
    UNCHANGED0.00%
    Silver US$/oz : 15.74
    UNCHANGED0.00%
    Palladium US$/oz : 684.35
    UNCHANGED0.00%
    Brent Crude : 60.32
    UNCHANGED0.00%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required